Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

19.41
-0.0500-0.26%
Post-market: 19.410.00000.00%19:30 EDT
Volume:264.45K
Turnover:5.15M
Market Cap:720.96M
PE:-2.62
High:20.35
Open:19.81
Low:19.11
Close:19.46
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:0.60
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:9.94
PE(LYR):-1.51

Loading ...

Aug 01, 2022

Major Issues Report

8-K - Current report
Aug 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 11, 2022

Major Issues Report

8-K - Current report
Jul 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 27, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 17, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 09, 2022

Major Issues Report

8-K - Current report
May 25, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 24, 2022

Major Issues Report

8-K/A [Amend] - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 02, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 05, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]